Most Recent

image: Opinion: Improving FDA Evaluations Without Jeopardizing Safety and Efficacy

Opinion: Improving FDA Evaluations Without Jeopardizing Safety and Efficacy

By | February 1, 2017

What can be done to lower development costs and drug prices?

4 Comments

New approaches to treating cancer have shown great promise, but they also come with serious risks that give us cause for concern.

1 Comment

image: Opinion: The Zika Effect

Opinion: The Zika Effect

By | May 27, 2016

Three reasons why virologists are flocking to study this emerging virus

3 Comments

image: Book Review: <em>Personal Trials</em>

Book Review: Personal Trials

By | March 22, 2016

At first blush, do-it-yourself clinical trials seem pointless and reckless. But a deeper truth pervades the research and the patients who drive it forward.

0 Comments

image: Opinion: Why Most TBI Studies Fail

Opinion: Why Most TBI Studies Fail

By | February 24, 2016

Thoughts on how to redesign clinical trials for traumatic brain injury

1 Comment

image: Opinion: Translation Nation

Opinion: Translation Nation

By | November 18, 2015

What’s in store for commercialization grants at the Canadian Institutes of Health Research?

0 Comments

image: Opinion: Public Data, Private Concerns

Opinion: Public Data, Private Concerns

By | May 20, 2015

Research participants aren’t always clear on open data policies when consenting to studies.

0 Comments

image: Opinion: Upgrading Cancer Prevention

Opinion: Upgrading Cancer Prevention

By | April 1, 2015

Preemptive detection and intervention will be key to easing the growing burden of cancer, particularly in developing countries.

1 Comment

image: Opinion: <em>Star Trek</em> Medicine

Opinion: Star Trek Medicine

By | November 6, 2014

An apology for basic research

2 Comments

image: Opinion: Separate Training from Research Budgets

Opinion: Separate Training from Research Budgets

By | October 7, 2014

In order to make the most of biomedical research funding and to better support trainees, institutions should recognize postdocs as employees.

2 Comments

Popular Now

  1. UC Berkeley Receives CRISPR Patent in Europe
    Daily News UC Berkeley Receives CRISPR Patent in Europe

    The European Patent Office will grant patent rights over the use of CRISPR in all cell types to a University of California team, contrasting with a recent decision in the U.S.

  2. DNA Replication Errors Contribute to Cancer Risk
  3. Should Healthy People Have Their Exomes Sequenced?
    Daily News Should Healthy People Have Their Exomes Sequenced?

    With its announced launch of a whole-exome sequencing service for apparently healthy individuals, Ambry Genetics is the latest company to enter this growing market. But whether these services are useful for most people remains up for debate.  

  4. Rethinking a Cancer Drug Target
    Daily News Rethinking a Cancer Drug Target

    The results of a CRISPR-Cas9 study suggest that MELK—a protein thought to play a critical role in cancer—is not necessary for cancer cell survival.

Business Birmingham